Effect of Mobilization Methods on CD34+ and Total Nucleated Cell Count and Their relation with Engraftment in Autologous Hematopoietic Stem Cell Transplantation


Beyler Ö., Pamukcuoğlu M., GÜNEŞ A. K., Korkmaz G., Ulusoy G., CERAN F., ...Daha Fazla

Eastern Journal of Medicine, cilt.29, sa.3, ss.344-348, 2024 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 3
  • Basım Tarihi: 2024
  • Doi Numarası: 10.5505/ejm.2024.08624
  • Dergi Adı: Eastern Journal of Medicine
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.344-348
  • Anahtar Kelimeler: CD34, engraftment, Stem cell
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Effective stem cell mobilization is crucial for autologous hematopoietic stem cell transplantation (auto-HSCT), impacting engraftment time and patient outcomes. This study compared three mobilization regimens (G-CSF alone, G-CSF & plerixafor, and chemotherapy & G-CSF) to determine their optimal use for maximizing CD34+ cell yield and minimizing engraftment times. A retrospective analysis of 227 auto-HSCT patients was conducted. Mobilization groups, CD34+ cell counts, total nucleated cells (TNC), total mononuclear cells (TMNC), and platelet/neutrophil engraftment times were analyzed. The average engraftment time was 11.6 days for platelets and 10.6 days for neutrophils. The chemotherapy & G-CSF arm yielded the highest CD34+ cells (p=0.001) and lowest TNC/TMNC (p=0.000). This arm also achieved the fastest platelet engraftment (p=0.017-0.001). Notably, age positively correlated with TNC count (p=0.022) and prolonged neutrophil engraftment (p=0.021). Gender did not significantly influence engraftment times. The chemotherapy & G-CSF regimen yielded the highest CD34+ cell count, lowest TNC/TMNC, and fastest platelet engraftment. However, neutrophil engraftment was positively associated with age, suggesting additional factors influence this outcome. Optimizing mobilization strategies and considering patient age are crucial for optimizing auto-HSCT outcomes.